Notably, a very recent study has proved that PD-L1 contributes to the transformation of breast cancer cells, with the PD-1/PD-L1 blockade inhibiting the epithelial–mesenchymal transition and improving the chemotherapy response [47]. Here, PDCD1 is linked to breast cancer.